NEUMORA THERAPEUTICS INC. - COMMON STOCK
0,7281
05-мая-25 12:08:29
15 мин. задержка
Акции
-0,0481
-6,20%
Сегодняшний диапазон
0,7267 - 0,7792
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
28 апр 2025 07:00:00 Источник Nasdaq GlobeNewswire
-
Neumora Therapeutics to Present at Leerink Global Healthcare Conference
04 мар 2025 08:30:00 Источник Nasdaq GlobeNewswire
-
03 мар 2025 07:00:00 Источник Nasdaq GlobeNewswire
-
Neumora Therapeutics Announces Leadership Transition
13 фев 2025 07:00:00 Источник Nasdaq GlobeNewswire
-
Neumora Therapeutics Reports Data from KOASTAL-1 Study of Navacaprant in Major Depressive Disorder
02 янв 2025 07:00:00 Источник Nasdaq GlobeNewswire
-
Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
12 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Neumora Therapeutics to Participate in Upcoming Conferences in November
06 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Neumora Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
29 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
14 авг 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Neumora Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
06 авг 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
20 июн 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression
14 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
07 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Neumora Therapeutics to Participate in Upcoming Conferences in May
06 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study
15 апр 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days
13 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
07 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer
22 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Neumora Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
02 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Neumora Therapeutics Appoints Jason Duncan as Chief Legal Officer
12 дек 2023 07:00:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >